SlideShare a Scribd company logo
Dr.RAJA RATNAKAR.ADDALA
1ST
YEAR PG
 It is a metabolic disorder of
multiple aetiology
characterized by chronic
HYPERGLYCAEMIA with
disturbance of carbohydrate,
fat & protein metabolism
resulting from defect in
insulin secretion, insulin
action, or both.
 250 BC- Apollonius of Memphis coined the name "diabetes”
meaning “siphon- to pass through”
 Thomas Willis in 1675 added "mellitus" to the word "diabetes”
 1869- Paul Langerhans, a German medical student, discovered
islet cells in the pancreas
 1910- Sharpey-Shafer of Edinburgh suggested a single chemical
was missing from the pancreas. He proposed calling this chemical
"insulin.”
 1922, Leonard Thompson became the first human to be
successfully treated for diabetes using insulin
 1921- Frederick G. Banting and Charles H. Best
successfully purified insulin from a dog's pancreas
 1923- 1st
Nobel prize for insulin 
 14th November of every
year: to mark the birthday
of Frederick Banting
 Around 7% of Indian Adults
 Most of the world’s Diabetics dwell in India
PREVALENCE OF
DIABETES-2010
Country Prevalence
India 7.1%
China 4.5%
USA 12.3%
Source: International
Diabetes Federation
1. Type 1 DM: -cell destructionβ
a. Immune-mediated
b. Idiopathic
2. Type 2 DM
3. Other specific types of diabetes:
a. Genetic defects of cell function: MODYβ
b. Genetic defects in insulin action
c. Diseases of the exocrine pancreas
d. Endocrinopathies
e. Drug- or chemical-induced
f. Infections
4. Gestational diabetes mellitus (GDM)
 How does this happen?
 Glucose enters the bloodstream, from
food we eat. This is later used for fuel
in the body. Our pancreas located near
the stomach makes insulin, which plays
a role in moving glucose to muscles,
liver cells, and fat.
 The pancreas then fails to make enough
insulin or the muscle or…
 Fat or liver cells fail to respond to the
insulin properly
 As a result, our body’s cells are
starving for energy and over time, high
blood glucose levels change our overall
health damaging the kidney, heart,
eyes, and nerves
HORMONES: which maintain
homeostasis of glucose
 ALPHA CELLS - GLUCAGON
 BETA CELLS- INSULIN, AMYLIN
Review of Anatomy and
Physiology
 Pancreas secretes 40-50
units of insulin daily in two
steps:
 Secreted at low levels during
fasting ( basal insulin
secretion)
 Increased levels after eating
(prandial)
 An early burst of insulin
occurs within 10 minutes of
eating
 Then proceeds with increasing
release as long as
hyperglycemia is present
 Insulin allows glucose to move
into cells to make energy
 Inhibits glucagon activity
 Type 1 diabetes is a chronic (lifelong) disease that
occurs when the pancreas does not produce
enough insulin to properly control blood sugar
levels.
What Causes Type 1 Diabetes
 The body's own immune system attacks and
destroys beta cells in the pancreas that are
responsible for creating the hormone insulin.
1.Type I
 formerly known as Insulin – Dependent Diabetes
Mellitus (IDDM) / juvenile onset
Autoimmune (Islet cell antibodies)
•Early introduction of cow’s milk and cereals
•Intake of medicine during pregnancy
•Indoor smoking of family members
destruction of beta cells of the pancreas  little or
no insulin production
requires daily insulin admin.
 may occur at any age, usually appears below age 15
 Type 2 diabetes formerly called non-insulin-
dependent diabetes is a disorder that is
characterized by high blood glucose in the context
of insulin resistance and relative insulin deficiency.
What Causes Type 2 Diabetes
 Type 2 diabetes occurs when the pancreas doesn't
make enough insulin or the cells of the body
become resistant to insulin.
2. Type II
 formerly known as Non Insulin–Dependent
Diabetes Mellitus (NIDDM) / maturity onset
 probably caused by:
 disturbance in insulin reception in the cells
  number of insulin receptors
 loss of beta cell responsiveness to glucose
leading to slow or  insulin release by the
pancreas
 occurs over age 40 but can occur in children
 common in overweight or obese
 The diabetes during pregnancy is called gestational
diabetes.
 It’s a temporary type of diabetes.
 The blood glusose level above 90mg% is considered
as a gestational diabetes.
 It may occur in 1st
Trimester, 2nd
Trimester or
3rd
Trimester.
 Hypertension
 Premature birth
 Caesarean birth
 Macrosomia
 Intrauterine mental retardation
 Hypoglycemia
 Jaundice
 Drug induced hyperglycemia:
◦ Beta-blockers - Inhibit insulin secretion.
◦ Calcium Channel Blockers - Inhibits secretion of insulin
by interfering with cytosolic calcium release.
◦ Corticosteroids - Cause peripheral insulin resistance and
gluconeogensis.
◦ Fluoroquinolones - Inhibits insulin secretion by blocking
ATP sensitive potassium channels.
◦ Naicin - They cause increased insulin resistance due to
increased free fatty acid mobilization.
◦ Phenothiazines - Inhibit insulin secretion.
◦ Protease Inhibitors - Inhibit the conversion of proinsulin
to insulin.
◦ Thiazide Diuretics - Inhibit insulin secretion due to
hypokalemia.
 Periodontal problems
 Xerostomia
 Abnormal taste
 Prolonged or recurrent fungal or bacterial infection
 Burning mouth syndrome
 Dental caries
 Halitosis
 Glossitis
 Candidiasis
 HbA1c is a test that measures the
amount of glycated hemoglobin in your
blood. Glycated hemoglobin is a
substance in red blood cells that is
formed when blood sugar (glucose)
attaches to hemoglobin.
 Glycosuria
 Ketone bodies
 Classic signs of
HYPERGLYSEMIA with RPG
≥200mg/dL
 OGTT ≥200mg/dL
 FPG ≥126mg/dL
 A1C ≥ 6.5%
The major components of the treatment of diabetes
are:
 Risk of diabetes typically increases in
following conditions:
 Older age (45 years or older)
 Less active (sedentary life)
 Overweight or obese
 Family history of diabetes
To minimize the risk of an intraoperative emergency,
clinicians need to consider some issues before initiating
dental treatment.
 Medical history: Take history and assess glycemic
control at initial appointment.
 Glucose levels
 Frequency of hypoglycemic episodes
 Medication, dosage and times.
 Consultation
 Scheduling of visits
 Morning appointment
 Do not coincide with peak activity.
 Diet
 Ensure that the patient has eaten normally and taken medications as
usual.
 Blood glucose monitoring
 Measured before beginning. (<70 mg/dL)
 Prophylactic antibiotics
 Established infection
 Pre-operation contamination wound
 Major surgery
 During treatment
 The most complication of DM occur is hypoglycemia episode.
 Hyperglycemia
 After treatment
 Infection control
 Dietary intake
 Medications : salicylates increase insulin secretion and
sensitivity avoid aspirin.
 Hypoglycemia, also called low blood
glucose or low blood sugar, occurs when
blood glucose drops below normal levels.
 It can lead to life-threatening consequences
 It occurs when the concentration of blood
glucose drops below 60 mg/dL
•Hypo glycaemia: administering oral glucose just before the
extraction.
•Blood glucose level is tested before surgical procedure.
•Drugs should be sugar-free.
•Amoxicillin is the drug of choice
•Drugs which can disturb diabetes control should be avoided
like steroids,ciprofloxacin,tetracycline.
•Acetoaminophen is the drug of choice.
•NSAIDs should be used with caution.
Numerous studies have demonstrated that the higher incidence of
wound infection associated with diabetes is because of
hyperglycaemia.
Tissue hypoglycaemia effects every aspect of wound healing by
adversely affecting the immune system including neutrophil and
lymphocyte function, chemotaxis and phagocytosis.
Diabetes have a negative impact on the vascular system. Vessels
of all sizes are affected , from the aorta down to the smallest
arterioles and capillaries.
Myocardial infarction caused by atherosclerosis of the coronary
arteries is the most common cause of death in diabetic patients.
 “Golden Rule” is that manage the patients as if they
are hypoglycemic.
 Placing the patient in the head-low-feet-up position
 If patient is conscious and able to take food by
mouth, give 15g of oral carbohydrate in one of the
following forms;
 4-6 ounce fruit juice or soda,
 3-4 teaspoon sugar,
 a hard candy.
 Small amount of honey/sweet syrup can also be placed in
the buccal fold
 In unconscious patients, give 50ml of dextrose in
50% concentration or 1mg glucagon
intaravenously, or give 1ml glucagon
intramuscularly at almost any body site.
 Following treatment, the signs and symptoms of
hypoglycemia should resolve in 10 to 15 minutes
 The patient should be observed for 30 to 60
minutes after recovery. Normal blood glucose level
is confirmed by a glucometer before the patient is
allowed to leave.
 Hyperglycemia, or high blood sugar is a
condition in which an excessive amount of
glucose circulates in the blood plasma.
 If your sugar is above 240 you should do the
followings:
 Drink lots of sugar-free fluids like water or diet drinks
 Eat the right food and the right amounts
 Check your blood sugars more often
 Check keytones if over 240
 Call doctor or nurse if you have a positive keytones
 Severe hyperglycemia
 A prolonged onset
 Ketoacidosis may develop with nausea, vomiting,
abdominal pain and acetone odor.
 Difficult to differentiate hypoglycemia or
hyperglycemia
 Hyperglycemia needs medical intervention and
insulin administration.
 While emergency, give glucose first !
 Small amount is unlikely to cause significant
harm.
.
 Patients, receiving good medical management
without serious complications such as renal disease,
hypertension, or coronary atherosclerotic heart
disease, can receive any indicated dental treatment
 Local anesthesia is preferred, but such patients can
even be safely treated in general anesthesia
 Patients with complications require different
treatment plan
Preoperative Stop biguanides
If
chlorpropamide,switch
to tolbutamide 1 wk
Stabilize on atleast b.d.
insulin for 2-3 days 1
day pre op short acting
insulin.
perioperative Omit oral
hypoglycaemic
Estimate blood glucose
level
Omit OHGs
Set up intravenous
infusion of 10%glucose
500 ml containing
actrapid 10 units plus kcl
1g at 8 am.
Estimate blood glucose
2hrly.
Postoperative Estimate blood glucose
4h
Continue infusion 4 h
Estimate blood glucose 4
hrly
On resuming normal
diet
Start sulphonylureas
Start usual regimen
Stop infusion ,start
normal insulin.
Minor operations Major operations
 Be physical active….
 Eat a healthy diet
 Abcs(know and control) a1c, blood
pressure, cholesterol, and smoking
 Take your medication
DIABETES

More Related Content

What's hot

Diabetes Hyperinsulinism Hypoglycemia
Diabetes Hyperinsulinism HypoglycemiaDiabetes Hyperinsulinism Hypoglycemia
Diabetes Hyperinsulinism Hypoglycemia
Hijab Siddiqi
 
Diabetes Mellitus(Past,Present and Future)
Diabetes Mellitus(Past,Present and Future)Diabetes Mellitus(Past,Present and Future)
Diabetes Mellitus(Past,Present and Future)
Vikas Reddy
 
Diabetes mellitus
Diabetes mellitus Diabetes mellitus
Diabetes mellitus
Jyoti Gaver
 
DIABETES MELLITUS an up-to-date 2017- 2018
DIABETES MELLITUS an up-to-date 2017- 2018DIABETES MELLITUS an up-to-date 2017- 2018
DIABETES MELLITUS an up-to-date 2017- 2018
Md. Zahirul Islam
 
Diabetes mellitus
Diabetes mellitus Diabetes mellitus
Diabetes mellitus
shafaatullahkhatt
 
Management of TYPE 1 DIABETES MELLITUS
Management of TYPE 1 DIABETES MELLITUSManagement of TYPE 1 DIABETES MELLITUS
Management of TYPE 1 DIABETES MELLITUS
Surabhi Yadav
 
Diabetes mellitus complete Disorder Exclusively for Nursing Students
Diabetes mellitus complete Disorder Exclusively for Nursing Students  Diabetes mellitus complete Disorder Exclusively for Nursing Students
Diabetes mellitus complete Disorder Exclusively for Nursing Students
Baljinder Singh
 
Diabetes mellitus pharma 3 fall 2018
Diabetes mellitus pharma 3 fall 2018Diabetes mellitus pharma 3 fall 2018
Diabetes mellitus pharma 3 fall 2018
AbdelNourBawadekji
 
Management of Diabetes Mellitus
Management of Diabetes MellitusManagement of Diabetes Mellitus
Management of Diabetes Mellitus
Carmela Domocmat
 
Diabetes
DiabetesDiabetes
Diabetes
akifab93
 
Diabetes Mellitus.ppt
Diabetes Mellitus.pptDiabetes Mellitus.ppt
Diabetes Mellitus.ppt
Shama
 
Diabetic Ketoacidosis
Diabetic KetoacidosisDiabetic Ketoacidosis
Diabetic Ketoacidosis
Irishkhriz Tambangan
 
Recent Advances in the Diagnosis and Treatment of Gestational Diabetes
Recent Advances in the Diagnosis and Treatment of Gestational DiabetesRecent Advances in the Diagnosis and Treatment of Gestational Diabetes
Recent Advances in the Diagnosis and Treatment of Gestational Diabetes
Chukwuma Onyeije, MD, FACOG
 
Diabetes nursing, medical, surgical managements
Diabetes nursing, medical, surgical managementsDiabetes nursing, medical, surgical managements
Diabetes nursing, medical, surgical managements
Reynel Dan
 
Treatment of Diabetes Mellitus
Treatment of Diabetes MellitusTreatment of Diabetes Mellitus
Treatment of Diabetes Mellitus
Eneutron
 
Diabetic nephropathy
Diabetic nephropathyDiabetic nephropathy
Diabetic nephropathy
KAVIYA AP
 
Diabetes Mellitus & Nurses Role
Diabetes Mellitus & Nurses RoleDiabetes Mellitus & Nurses Role
Diabetes Mellitus & Nurses Role
Prof Vijayraddi
 
Hyperemesis Gravidarum by Dr Alka Mukherjee Dr Apurva Mukherjee
Hyperemesis Gravidarum by Dr Alka Mukherjee Dr Apurva MukherjeeHyperemesis Gravidarum by Dr Alka Mukherjee Dr Apurva Mukherjee
Hyperemesis Gravidarum by Dr Alka Mukherjee Dr Apurva Mukherjee
alka mukherjee
 
Endocrine ppt
Endocrine pptEndocrine ppt
Endocrine ppt
EMSMedic79
 
7349728 diabetes-nursing-care
7349728 diabetes-nursing-care7349728 diabetes-nursing-care
7349728 diabetes-nursing-care
Ngaire Taylor
 

What's hot (20)

Diabetes Hyperinsulinism Hypoglycemia
Diabetes Hyperinsulinism HypoglycemiaDiabetes Hyperinsulinism Hypoglycemia
Diabetes Hyperinsulinism Hypoglycemia
 
Diabetes Mellitus(Past,Present and Future)
Diabetes Mellitus(Past,Present and Future)Diabetes Mellitus(Past,Present and Future)
Diabetes Mellitus(Past,Present and Future)
 
Diabetes mellitus
Diabetes mellitus Diabetes mellitus
Diabetes mellitus
 
DIABETES MELLITUS an up-to-date 2017- 2018
DIABETES MELLITUS an up-to-date 2017- 2018DIABETES MELLITUS an up-to-date 2017- 2018
DIABETES MELLITUS an up-to-date 2017- 2018
 
Diabetes mellitus
Diabetes mellitus Diabetes mellitus
Diabetes mellitus
 
Management of TYPE 1 DIABETES MELLITUS
Management of TYPE 1 DIABETES MELLITUSManagement of TYPE 1 DIABETES MELLITUS
Management of TYPE 1 DIABETES MELLITUS
 
Diabetes mellitus complete Disorder Exclusively for Nursing Students
Diabetes mellitus complete Disorder Exclusively for Nursing Students  Diabetes mellitus complete Disorder Exclusively for Nursing Students
Diabetes mellitus complete Disorder Exclusively for Nursing Students
 
Diabetes mellitus pharma 3 fall 2018
Diabetes mellitus pharma 3 fall 2018Diabetes mellitus pharma 3 fall 2018
Diabetes mellitus pharma 3 fall 2018
 
Management of Diabetes Mellitus
Management of Diabetes MellitusManagement of Diabetes Mellitus
Management of Diabetes Mellitus
 
Diabetes
DiabetesDiabetes
Diabetes
 
Diabetes Mellitus.ppt
Diabetes Mellitus.pptDiabetes Mellitus.ppt
Diabetes Mellitus.ppt
 
Diabetic Ketoacidosis
Diabetic KetoacidosisDiabetic Ketoacidosis
Diabetic Ketoacidosis
 
Recent Advances in the Diagnosis and Treatment of Gestational Diabetes
Recent Advances in the Diagnosis and Treatment of Gestational DiabetesRecent Advances in the Diagnosis and Treatment of Gestational Diabetes
Recent Advances in the Diagnosis and Treatment of Gestational Diabetes
 
Diabetes nursing, medical, surgical managements
Diabetes nursing, medical, surgical managementsDiabetes nursing, medical, surgical managements
Diabetes nursing, medical, surgical managements
 
Treatment of Diabetes Mellitus
Treatment of Diabetes MellitusTreatment of Diabetes Mellitus
Treatment of Diabetes Mellitus
 
Diabetic nephropathy
Diabetic nephropathyDiabetic nephropathy
Diabetic nephropathy
 
Diabetes Mellitus & Nurses Role
Diabetes Mellitus & Nurses RoleDiabetes Mellitus & Nurses Role
Diabetes Mellitus & Nurses Role
 
Hyperemesis Gravidarum by Dr Alka Mukherjee Dr Apurva Mukherjee
Hyperemesis Gravidarum by Dr Alka Mukherjee Dr Apurva MukherjeeHyperemesis Gravidarum by Dr Alka Mukherjee Dr Apurva Mukherjee
Hyperemesis Gravidarum by Dr Alka Mukherjee Dr Apurva Mukherjee
 
Endocrine ppt
Endocrine pptEndocrine ppt
Endocrine ppt
 
7349728 diabetes-nursing-care
7349728 diabetes-nursing-care7349728 diabetes-nursing-care
7349728 diabetes-nursing-care
 

Similar to DIABETES

Pancreatic diseases
Pancreatic diseasesPancreatic diseases
Pancreatic diseases
Tousif Khan
 
#Diabetes mellitus disease ppt presentation
#Diabetes mellitus disease ppt presentation#Diabetes mellitus disease ppt presentation
#Diabetes mellitus disease ppt presentation
rk17602629
 
Diabete mellitus
Diabete mellitus Diabete mellitus
Diabete mellitus
Zahra Khan
 
Hypoglysemia.pptx
Hypoglysemia.pptxHypoglysemia.pptx
Hypoglysemia.pptx
ABHIJIT BHOYAR
 
Drugs used in Endocrine Disorders.pdf rf
Drugs used in Endocrine Disorders.pdf rfDrugs used in Endocrine Disorders.pdf rf
Drugs used in Endocrine Disorders.pdf rf
502poojan
 
Pancreatic islets
Pancreatic isletsPancreatic islets
Pancreatic islets
vanajayarrlagadda
 
Endocrine disorder Diabetes Mellitus (DM)
Endocrine disorder   Diabetes Mellitus (DM) Endocrine disorder   Diabetes Mellitus (DM)
Endocrine disorder Diabetes Mellitus (DM)
TheRoyAshish
 
Diabetes and metabolic syndrome jevi
Diabetes and metabolic syndrome jeviDiabetes and metabolic syndrome jevi
Diabetes and metabolic syndrome jevi
Nirmala Sankaradoss
 
diabetes for g.nm.pptx
diabetes for g.nm.pptxdiabetes for g.nm.pptx
Blood Sugar Presentation.pptxjjkkkkkkkkkkk
Blood Sugar Presentation.pptxjjkkkkkkkkkkkBlood Sugar Presentation.pptxjjkkkkkkkkkkk
Blood Sugar Presentation.pptxjjkkkkkkkkkkk
RawalRafiqLeghari
 
diabetes mellitus and insulin docum pptx
diabetes mellitus and insulin docum pptxdiabetes mellitus and insulin docum pptx
diabetes mellitus and insulin docum pptx
jerriecesar
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
Sara Ravi
 
Diabetes description
Diabetes descriptionDiabetes description
Diabetes description
DipeshPrajapati12
 
...DIAGNOSIS OF DIABETES MELLITUS...
...DIAGNOSIS OF DIABETES MELLITUS......DIAGNOSIS OF DIABETES MELLITUS...
...DIAGNOSIS OF DIABETES MELLITUS...
Dr.Subir Kumar
 
Diabetes.pdf
Diabetes.pdfDiabetes.pdf
Diabetes.pdf
JustinMutua
 
diabetes word document
diabetes word document diabetes word document
diabetes word document
kavyayadav28
 
Presentation on Hypoglycemia
Presentation on HypoglycemiaPresentation on Hypoglycemia
Presentation on Hypoglycemia
BANAFULRoy
 
Blood glucose monitoring
Blood glucose monitoringBlood glucose monitoring
Blood glucose monitoring
Bari Berger
 
Diabetes Mellitus
Diabetes MellitusDiabetes Mellitus
Diabetes Mellitus
Tosca Torres
 
Approach to Diabetes mellitus.ppt.pptx
Approach to Diabetes mellitus.ppt.pptxApproach to Diabetes mellitus.ppt.pptx
Approach to Diabetes mellitus.ppt.pptx
FebithaVP
 

Similar to DIABETES (20)

Pancreatic diseases
Pancreatic diseasesPancreatic diseases
Pancreatic diseases
 
#Diabetes mellitus disease ppt presentation
#Diabetes mellitus disease ppt presentation#Diabetes mellitus disease ppt presentation
#Diabetes mellitus disease ppt presentation
 
Diabete mellitus
Diabete mellitus Diabete mellitus
Diabete mellitus
 
Hypoglysemia.pptx
Hypoglysemia.pptxHypoglysemia.pptx
Hypoglysemia.pptx
 
Drugs used in Endocrine Disorders.pdf rf
Drugs used in Endocrine Disorders.pdf rfDrugs used in Endocrine Disorders.pdf rf
Drugs used in Endocrine Disorders.pdf rf
 
Pancreatic islets
Pancreatic isletsPancreatic islets
Pancreatic islets
 
Endocrine disorder Diabetes Mellitus (DM)
Endocrine disorder   Diabetes Mellitus (DM) Endocrine disorder   Diabetes Mellitus (DM)
Endocrine disorder Diabetes Mellitus (DM)
 
Diabetes and metabolic syndrome jevi
Diabetes and metabolic syndrome jeviDiabetes and metabolic syndrome jevi
Diabetes and metabolic syndrome jevi
 
diabetes for g.nm.pptx
diabetes for g.nm.pptxdiabetes for g.nm.pptx
diabetes for g.nm.pptx
 
Blood Sugar Presentation.pptxjjkkkkkkkkkkk
Blood Sugar Presentation.pptxjjkkkkkkkkkkkBlood Sugar Presentation.pptxjjkkkkkkkkkkk
Blood Sugar Presentation.pptxjjkkkkkkkkkkk
 
diabetes mellitus and insulin docum pptx
diabetes mellitus and insulin docum pptxdiabetes mellitus and insulin docum pptx
diabetes mellitus and insulin docum pptx
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
 
Diabetes description
Diabetes descriptionDiabetes description
Diabetes description
 
...DIAGNOSIS OF DIABETES MELLITUS...
...DIAGNOSIS OF DIABETES MELLITUS......DIAGNOSIS OF DIABETES MELLITUS...
...DIAGNOSIS OF DIABETES MELLITUS...
 
Diabetes.pdf
Diabetes.pdfDiabetes.pdf
Diabetes.pdf
 
diabetes word document
diabetes word document diabetes word document
diabetes word document
 
Presentation on Hypoglycemia
Presentation on HypoglycemiaPresentation on Hypoglycemia
Presentation on Hypoglycemia
 
Blood glucose monitoring
Blood glucose monitoringBlood glucose monitoring
Blood glucose monitoring
 
Diabetes Mellitus
Diabetes MellitusDiabetes Mellitus
Diabetes Mellitus
 
Approach to Diabetes mellitus.ppt.pptx
Approach to Diabetes mellitus.ppt.pptxApproach to Diabetes mellitus.ppt.pptx
Approach to Diabetes mellitus.ppt.pptx
 

Recently uploaded

Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
University of Maribor
 
SAR of Medicinal Chemistry 1st by dk.pdf
SAR of Medicinal Chemistry 1st by dk.pdfSAR of Medicinal Chemistry 1st by dk.pdf
SAR of Medicinal Chemistry 1st by dk.pdf
KrushnaDarade1
 
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptxANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
RASHMI M G
 
ESR spectroscopy in liquid food and beverages.pptx
ESR spectroscopy in liquid food and beverages.pptxESR spectroscopy in liquid food and beverages.pptx
ESR spectroscopy in liquid food and beverages.pptx
PRIYANKA PATEL
 
Randomised Optimisation Algorithms in DAPHNE
Randomised Optimisation Algorithms in DAPHNERandomised Optimisation Algorithms in DAPHNE
Randomised Optimisation Algorithms in DAPHNE
University of Maribor
 
mô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốt
mô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốtmô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốt
mô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốt
HongcNguyn6
 
THEMATIC APPERCEPTION TEST(TAT) cognitive abilities, creativity, and critic...
THEMATIC  APPERCEPTION  TEST(TAT) cognitive abilities, creativity, and critic...THEMATIC  APPERCEPTION  TEST(TAT) cognitive abilities, creativity, and critic...
THEMATIC APPERCEPTION TEST(TAT) cognitive abilities, creativity, and critic...
Abdul Wali Khan University Mardan,kP,Pakistan
 
Eukaryotic Transcription Presentation.pptx
Eukaryotic Transcription Presentation.pptxEukaryotic Transcription Presentation.pptx
Eukaryotic Transcription Presentation.pptx
RitabrataSarkar3
 
Chapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisisChapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisis
tonzsalvador2222
 
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
Sérgio Sacani
 
Phenomics assisted breeding in crop improvement
Phenomics assisted breeding in crop improvementPhenomics assisted breeding in crop improvement
Phenomics assisted breeding in crop improvement
IshaGoswami9
 
Micronuclei test.M.sc.zoology.fisheries.
Micronuclei test.M.sc.zoology.fisheries.Micronuclei test.M.sc.zoology.fisheries.
Micronuclei test.M.sc.zoology.fisheries.
Aditi Bajpai
 
Medical Orthopedic PowerPoint Templates.pptx
Medical Orthopedic PowerPoint Templates.pptxMedical Orthopedic PowerPoint Templates.pptx
Medical Orthopedic PowerPoint Templates.pptx
terusbelajar5
 
aziz sancar nobel prize winner: from mardin to nobel
aziz sancar nobel prize winner: from mardin to nobelaziz sancar nobel prize winner: from mardin to nobel
aziz sancar nobel prize winner: from mardin to nobel
İsa Badur
 
Shallowest Oil Discovery of Turkiye.pptx
Shallowest Oil Discovery of Turkiye.pptxShallowest Oil Discovery of Turkiye.pptx
Shallowest Oil Discovery of Turkiye.pptx
Gokturk Mehmet Dilci
 
The binding of cosmological structures by massless topological defects
The binding of cosmological structures by massless topological defectsThe binding of cosmological structures by massless topological defects
The binding of cosmological structures by massless topological defects
Sérgio Sacani
 
Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.
Nistarini College, Purulia (W.B) India
 
8.Isolation of pure cultures and preservation of cultures.pdf
8.Isolation of pure cultures and preservation of cultures.pdf8.Isolation of pure cultures and preservation of cultures.pdf
8.Isolation of pure cultures and preservation of cultures.pdf
by6843629
 
Nucleophilic Addition of carbonyl compounds.pptx
Nucleophilic Addition of carbonyl  compounds.pptxNucleophilic Addition of carbonyl  compounds.pptx
Nucleophilic Addition of carbonyl compounds.pptx
SSR02
 
NuGOweek 2024 Ghent programme overview flyer
NuGOweek 2024 Ghent programme overview flyerNuGOweek 2024 Ghent programme overview flyer
NuGOweek 2024 Ghent programme overview flyer
pablovgd
 

Recently uploaded (20)

Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
 
SAR of Medicinal Chemistry 1st by dk.pdf
SAR of Medicinal Chemistry 1st by dk.pdfSAR of Medicinal Chemistry 1st by dk.pdf
SAR of Medicinal Chemistry 1st by dk.pdf
 
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptxANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
ANAMOLOUS SECONDARY GROWTH IN DICOT ROOTS.pptx
 
ESR spectroscopy in liquid food and beverages.pptx
ESR spectroscopy in liquid food and beverages.pptxESR spectroscopy in liquid food and beverages.pptx
ESR spectroscopy in liquid food and beverages.pptx
 
Randomised Optimisation Algorithms in DAPHNE
Randomised Optimisation Algorithms in DAPHNERandomised Optimisation Algorithms in DAPHNE
Randomised Optimisation Algorithms in DAPHNE
 
mô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốt
mô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốtmô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốt
mô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốt
 
THEMATIC APPERCEPTION TEST(TAT) cognitive abilities, creativity, and critic...
THEMATIC  APPERCEPTION  TEST(TAT) cognitive abilities, creativity, and critic...THEMATIC  APPERCEPTION  TEST(TAT) cognitive abilities, creativity, and critic...
THEMATIC APPERCEPTION TEST(TAT) cognitive abilities, creativity, and critic...
 
Eukaryotic Transcription Presentation.pptx
Eukaryotic Transcription Presentation.pptxEukaryotic Transcription Presentation.pptx
Eukaryotic Transcription Presentation.pptx
 
Chapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisisChapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisis
 
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
 
Phenomics assisted breeding in crop improvement
Phenomics assisted breeding in crop improvementPhenomics assisted breeding in crop improvement
Phenomics assisted breeding in crop improvement
 
Micronuclei test.M.sc.zoology.fisheries.
Micronuclei test.M.sc.zoology.fisheries.Micronuclei test.M.sc.zoology.fisheries.
Micronuclei test.M.sc.zoology.fisheries.
 
Medical Orthopedic PowerPoint Templates.pptx
Medical Orthopedic PowerPoint Templates.pptxMedical Orthopedic PowerPoint Templates.pptx
Medical Orthopedic PowerPoint Templates.pptx
 
aziz sancar nobel prize winner: from mardin to nobel
aziz sancar nobel prize winner: from mardin to nobelaziz sancar nobel prize winner: from mardin to nobel
aziz sancar nobel prize winner: from mardin to nobel
 
Shallowest Oil Discovery of Turkiye.pptx
Shallowest Oil Discovery of Turkiye.pptxShallowest Oil Discovery of Turkiye.pptx
Shallowest Oil Discovery of Turkiye.pptx
 
The binding of cosmological structures by massless topological defects
The binding of cosmological structures by massless topological defectsThe binding of cosmological structures by massless topological defects
The binding of cosmological structures by massless topological defects
 
Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.
 
8.Isolation of pure cultures and preservation of cultures.pdf
8.Isolation of pure cultures and preservation of cultures.pdf8.Isolation of pure cultures and preservation of cultures.pdf
8.Isolation of pure cultures and preservation of cultures.pdf
 
Nucleophilic Addition of carbonyl compounds.pptx
Nucleophilic Addition of carbonyl  compounds.pptxNucleophilic Addition of carbonyl  compounds.pptx
Nucleophilic Addition of carbonyl compounds.pptx
 
NuGOweek 2024 Ghent programme overview flyer
NuGOweek 2024 Ghent programme overview flyerNuGOweek 2024 Ghent programme overview flyer
NuGOweek 2024 Ghent programme overview flyer
 

DIABETES

  • 1.
  • 3.  It is a metabolic disorder of multiple aetiology characterized by chronic HYPERGLYCAEMIA with disturbance of carbohydrate, fat & protein metabolism resulting from defect in insulin secretion, insulin action, or both.
  • 4.  250 BC- Apollonius of Memphis coined the name "diabetes” meaning “siphon- to pass through”  Thomas Willis in 1675 added "mellitus" to the word "diabetes”  1869- Paul Langerhans, a German medical student, discovered islet cells in the pancreas  1910- Sharpey-Shafer of Edinburgh suggested a single chemical was missing from the pancreas. He proposed calling this chemical "insulin.”  1922, Leonard Thompson became the first human to be successfully treated for diabetes using insulin
  • 5.  1921- Frederick G. Banting and Charles H. Best successfully purified insulin from a dog's pancreas  1923- 1st Nobel prize for insulin 
  • 6.  14th November of every year: to mark the birthday of Frederick Banting
  • 7.  Around 7% of Indian Adults  Most of the world’s Diabetics dwell in India PREVALENCE OF DIABETES-2010 Country Prevalence India 7.1% China 4.5% USA 12.3% Source: International Diabetes Federation
  • 8. 1. Type 1 DM: -cell destructionβ a. Immune-mediated b. Idiopathic 2. Type 2 DM 3. Other specific types of diabetes: a. Genetic defects of cell function: MODYβ b. Genetic defects in insulin action c. Diseases of the exocrine pancreas d. Endocrinopathies e. Drug- or chemical-induced f. Infections 4. Gestational diabetes mellitus (GDM)
  • 9.  How does this happen?  Glucose enters the bloodstream, from food we eat. This is later used for fuel in the body. Our pancreas located near the stomach makes insulin, which plays a role in moving glucose to muscles, liver cells, and fat.  The pancreas then fails to make enough insulin or the muscle or…  Fat or liver cells fail to respond to the insulin properly  As a result, our body’s cells are starving for energy and over time, high blood glucose levels change our overall health damaging the kidney, heart, eyes, and nerves
  • 10. HORMONES: which maintain homeostasis of glucose  ALPHA CELLS - GLUCAGON  BETA CELLS- INSULIN, AMYLIN Review of Anatomy and Physiology
  • 11.  Pancreas secretes 40-50 units of insulin daily in two steps:  Secreted at low levels during fasting ( basal insulin secretion)  Increased levels after eating (prandial)  An early burst of insulin occurs within 10 minutes of eating  Then proceeds with increasing release as long as hyperglycemia is present
  • 12.  Insulin allows glucose to move into cells to make energy  Inhibits glucagon activity
  • 13.  Type 1 diabetes is a chronic (lifelong) disease that occurs when the pancreas does not produce enough insulin to properly control blood sugar levels. What Causes Type 1 Diabetes  The body's own immune system attacks and destroys beta cells in the pancreas that are responsible for creating the hormone insulin.
  • 14. 1.Type I  formerly known as Insulin – Dependent Diabetes Mellitus (IDDM) / juvenile onset Autoimmune (Islet cell antibodies) •Early introduction of cow’s milk and cereals •Intake of medicine during pregnancy •Indoor smoking of family members destruction of beta cells of the pancreas  little or no insulin production requires daily insulin admin.  may occur at any age, usually appears below age 15
  • 15.
  • 16.
  • 17.  Type 2 diabetes formerly called non-insulin- dependent diabetes is a disorder that is characterized by high blood glucose in the context of insulin resistance and relative insulin deficiency. What Causes Type 2 Diabetes  Type 2 diabetes occurs when the pancreas doesn't make enough insulin or the cells of the body become resistant to insulin.
  • 18. 2. Type II  formerly known as Non Insulin–Dependent Diabetes Mellitus (NIDDM) / maturity onset  probably caused by:  disturbance in insulin reception in the cells   number of insulin receptors  loss of beta cell responsiveness to glucose leading to slow or  insulin release by the pancreas  occurs over age 40 but can occur in children  common in overweight or obese
  • 19.
  • 20.
  • 21.
  • 22.  The diabetes during pregnancy is called gestational diabetes.  It’s a temporary type of diabetes.  The blood glusose level above 90mg% is considered as a gestational diabetes.  It may occur in 1st Trimester, 2nd Trimester or 3rd Trimester.
  • 23.
  • 24.
  • 25.  Hypertension  Premature birth  Caesarean birth
  • 26.  Macrosomia  Intrauterine mental retardation  Hypoglycemia  Jaundice
  • 27.
  • 28.
  • 29.
  • 30.  Drug induced hyperglycemia: ◦ Beta-blockers - Inhibit insulin secretion. ◦ Calcium Channel Blockers - Inhibits secretion of insulin by interfering with cytosolic calcium release. ◦ Corticosteroids - Cause peripheral insulin resistance and gluconeogensis. ◦ Fluoroquinolones - Inhibits insulin secretion by blocking ATP sensitive potassium channels. ◦ Naicin - They cause increased insulin resistance due to increased free fatty acid mobilization. ◦ Phenothiazines - Inhibit insulin secretion. ◦ Protease Inhibitors - Inhibit the conversion of proinsulin to insulin. ◦ Thiazide Diuretics - Inhibit insulin secretion due to hypokalemia.
  • 31.  Periodontal problems  Xerostomia  Abnormal taste  Prolonged or recurrent fungal or bacterial infection  Burning mouth syndrome  Dental caries  Halitosis  Glossitis  Candidiasis
  • 32.
  • 33.
  • 34.
  • 35.  HbA1c is a test that measures the amount of glycated hemoglobin in your blood. Glycated hemoglobin is a substance in red blood cells that is formed when blood sugar (glucose) attaches to hemoglobin.
  • 37.  Classic signs of HYPERGLYSEMIA with RPG ≥200mg/dL  OGTT ≥200mg/dL  FPG ≥126mg/dL  A1C ≥ 6.5%
  • 38.
  • 39. The major components of the treatment of diabetes are:
  • 40.  Risk of diabetes typically increases in following conditions:  Older age (45 years or older)  Less active (sedentary life)  Overweight or obese  Family history of diabetes
  • 41. To minimize the risk of an intraoperative emergency, clinicians need to consider some issues before initiating dental treatment.  Medical history: Take history and assess glycemic control at initial appointment.  Glucose levels  Frequency of hypoglycemic episodes  Medication, dosage and times.  Consultation
  • 42.  Scheduling of visits  Morning appointment  Do not coincide with peak activity.  Diet  Ensure that the patient has eaten normally and taken medications as usual.  Blood glucose monitoring  Measured before beginning. (<70 mg/dL)  Prophylactic antibiotics  Established infection  Pre-operation contamination wound  Major surgery
  • 43.  During treatment  The most complication of DM occur is hypoglycemia episode.  Hyperglycemia  After treatment  Infection control  Dietary intake  Medications : salicylates increase insulin secretion and sensitivity avoid aspirin.
  • 44.  Hypoglycemia, also called low blood glucose or low blood sugar, occurs when blood glucose drops below normal levels.  It can lead to life-threatening consequences  It occurs when the concentration of blood glucose drops below 60 mg/dL
  • 45.
  • 46. •Hypo glycaemia: administering oral glucose just before the extraction. •Blood glucose level is tested before surgical procedure. •Drugs should be sugar-free. •Amoxicillin is the drug of choice •Drugs which can disturb diabetes control should be avoided like steroids,ciprofloxacin,tetracycline. •Acetoaminophen is the drug of choice. •NSAIDs should be used with caution.
  • 47. Numerous studies have demonstrated that the higher incidence of wound infection associated with diabetes is because of hyperglycaemia. Tissue hypoglycaemia effects every aspect of wound healing by adversely affecting the immune system including neutrophil and lymphocyte function, chemotaxis and phagocytosis. Diabetes have a negative impact on the vascular system. Vessels of all sizes are affected , from the aorta down to the smallest arterioles and capillaries. Myocardial infarction caused by atherosclerosis of the coronary arteries is the most common cause of death in diabetic patients.
  • 48.
  • 49.  “Golden Rule” is that manage the patients as if they are hypoglycemic.  Placing the patient in the head-low-feet-up position
  • 50.  If patient is conscious and able to take food by mouth, give 15g of oral carbohydrate in one of the following forms;  4-6 ounce fruit juice or soda,  3-4 teaspoon sugar,  a hard candy.  Small amount of honey/sweet syrup can also be placed in the buccal fold
  • 51.  In unconscious patients, give 50ml of dextrose in 50% concentration or 1mg glucagon intaravenously, or give 1ml glucagon intramuscularly at almost any body site.  Following treatment, the signs and symptoms of hypoglycemia should resolve in 10 to 15 minutes  The patient should be observed for 30 to 60 minutes after recovery. Normal blood glucose level is confirmed by a glucometer before the patient is allowed to leave.
  • 52.  Hyperglycemia, or high blood sugar is a condition in which an excessive amount of glucose circulates in the blood plasma.
  • 53.
  • 54.  If your sugar is above 240 you should do the followings:  Drink lots of sugar-free fluids like water or diet drinks  Eat the right food and the right amounts  Check your blood sugars more often  Check keytones if over 240  Call doctor or nurse if you have a positive keytones
  • 55.  Severe hyperglycemia  A prolonged onset  Ketoacidosis may develop with nausea, vomiting, abdominal pain and acetone odor.  Difficult to differentiate hypoglycemia or hyperglycemia  Hyperglycemia needs medical intervention and insulin administration.  While emergency, give glucose first !  Small amount is unlikely to cause significant harm. .
  • 56.
  • 57.  Patients, receiving good medical management without serious complications such as renal disease, hypertension, or coronary atherosclerotic heart disease, can receive any indicated dental treatment  Local anesthesia is preferred, but such patients can even be safely treated in general anesthesia  Patients with complications require different treatment plan
  • 58. Preoperative Stop biguanides If chlorpropamide,switch to tolbutamide 1 wk Stabilize on atleast b.d. insulin for 2-3 days 1 day pre op short acting insulin. perioperative Omit oral hypoglycaemic Estimate blood glucose level Omit OHGs Set up intravenous infusion of 10%glucose 500 ml containing actrapid 10 units plus kcl 1g at 8 am. Estimate blood glucose 2hrly. Postoperative Estimate blood glucose 4h Continue infusion 4 h Estimate blood glucose 4 hrly On resuming normal diet Start sulphonylureas Start usual regimen Stop infusion ,start normal insulin. Minor operations Major operations
  • 59.
  • 60.  Be physical active….  Eat a healthy diet  Abcs(know and control) a1c, blood pressure, cholesterol, and smoking  Take your medication

Editor's Notes

  1. Too much emptying of the urine Thomas Willis who in 1675 added &amp;quot;mellitus&amp;quot; to the word &amp;quot;diabetes&amp;quot; as a designation for the disease, when he noticed the urine of a diabetic had a sweet taste (glycosuria) Paul Langerhans, noted that the pancreas contains two distinct groups of cells—the acinar cells, which secrete digestive enzymes, and cells that are clustered in islands, or islets, which he suggested served a second function.
  2. Banting announced that he would share his prize with Best; Macleod did the same with Collip Frederick Sanger established the amino acid sequence Nobel Prize in 1958. Dorothy Hodgkin elucidated insulin&amp;apos;s three-dimensional structure. Insulin was the hormone for which Yalow and Berson first developed the radioimmunoassay, which was recognized with the Nobel Prize in 1977
  3. India-7.1% China-4.5% USA-12.3 %
  4. 3.Other specific Types of DM: a. Genetic defects of beta cell function : MODY b. Genetic defects in insulin action: 1. Type A insulin resistance     2. Leprechaunism     3. Rabson-Mendenhall syndrome     4. Lipodystrophy syndromes c. Diseases of the exocrine pancreas—pancreatitis, pancreatectomy, neoplasia, cystic fibrosis, hemochromatosis, fibrocalculous pancreatopathy, mutations in carboxyl ester lipase d. Endocrinopathies-—acromegaly, Cushing&amp;apos;s syndrome, glucagonoma, pheochromocytoma, hyperthyroidism, somatostatinoma, aldosteronoma e. Drug or Chemical induced-—Vacor, pentamidine, nicotinic acid, glucocorticoids, thyroid hormone, diazoxide, β-adrenergic agonists, thiazides, phenytoin, α -interferon, protease inhibitors, clozapine F. Infections—congenital rubella, cytomegalovirus, coxsackie the terms insulin-dependent diabetes mellitus (IDDM) and noninsulin-dependent diabetes mellitus (NIDDM) are obsolete. Since many individuals with type 2 DM eventually require insulin treatment for control of glycemia, the use of the term NIDDM generated considerable confusion. A second difference is that age is not a criterion in the classification system. Although type 1 DM most commonly develops before the age of 30, an autoimmune beta cell destructive process can develop at any age. It is estimated that between 5 and 10% of individuals who develop DM after age 30 have type 1 DM. Likewise, type 2 DM more typically develops with increasing age but is now being diagnosed more frequently in children and young adults, particularly in obese adolescents.